Year |
Citation |
Score |
2018 |
Zolkind P, Przybylski D, Marjanovic N, Nguyen L, Lin T, Johanns T, Alexandrov A, Zhou L, Allen CT, Miceli AP, Schreiber RD, Artyomov M, Dunn GP, Uppaluri R. Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma. Oncotarget. 9: 4109-4119. PMID 29423108 DOI: 10.18632/Oncotarget.23751 |
0.422 |
|
2016 |
Griffith OL, Chan SR, Griffith M, Krysiak K, Skidmore ZL, Hundal J, Allen JA, Arthur CD, Runci D, Bugatti M, Miceli AP, Schmidt H, Trani L, Kanchi KL, Miller CA, et al. Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas. Cell Reports. 17: 249-60. PMID 27681435 DOI: 10.1016/J.Celrep.2016.08.076 |
0.479 |
|
2016 |
Mardis E, Griffith OL, Szeman RC, Griffith M, Krysiak K, Skidmore Z, Hundal J, Allen JA, Cora A, Miceli AP, Schmidt H, Trani L, Kanchi K, Miller CA, Larson DE, et al. Abstract IA20: Genomics of a STAT1 knockout mouse model of human ER+ breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-Ia20 |
0.363 |
|
2014 |
Maggi LB, Winkeler CL, Miceli AP, Apicelli AJ, Brady SN, Kuchenreuther MJ, Weber JD. ARF tumor suppression in the nucleolus. Biochimica Et Biophysica Acta. 1842: 831-9. PMID 24525025 DOI: 10.1016/J.Bbadis.2014.01.016 |
0.44 |
|
2012 |
Miceli AP, Saporita AJ, Weber JD. Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint. Molecular and Cellular Biology. 32: 348-64. PMID 22064482 DOI: 10.1128/Mcb.06030-11 |
0.73 |
|
2011 |
Zhang Y, Forys JT, Miceli AP, Gwinn AS, Weber JD. Identification of DHX33 as a mediator of rRNA synthesis and cell growth. Molecular and Cellular Biology. 31: 4676-91. PMID 21930779 DOI: 10.1128/Mcb.05832-11 |
0.688 |
|
2008 |
Apicelli AJ, Maggi LB, Hirbe AC, Miceli AP, Olanich ME, Schulte-Winkeler CL, Saporita AJ, Kuchenreuther M, Sanchez J, Weilbaecher K, Weber JD. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Molecular and Cellular Biology. 28: 1068-80. PMID 18070929 DOI: 10.1128/Mcb.00484-07 |
0.592 |
|
2006 |
Saab R, Bills JL, Miceli AP, Anderson CM, Khoury JD, Fry DW, Navid F, Houghton PJ, Skapek SX. Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Molecular Cancer Therapeutics. 5: 1299-308. PMID 16731763 DOI: 10.1158/1535-7163.MCT-05-0383 |
0.304 |
|
Show low-probability matches. |